Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D5X9 | ISIN: CA64119M1059 | Ticker-Symbol: PF0
Frankfurt
28.03.24
16:51 Uhr
0,156 Euro
+0,002
+1,30 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NETRAMARK HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
NETRAMARK HOLDINGS INC 5-Tage-Chart

Aktuelle News zur NETRAMARK Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.03.Netramark Holdings Inc: Netramark signs NetraAI contract with pharma company1
12.03.Netramark Signs Contract With Pharmaceutical Company To Deliver Clinical Trial Insights Regarding Efficacy And Placebo Response1
11.03.Netramark Holdings Inc: Netramark Holdings finds Parkinson's subtypes1
11.03.Netramark's Ai-based Clinical Solution Identifies Parkinson's Disease Subtypes Linked By Mitochondrial, Microbiome And Immune Signaling1
29.02.Netramark To Present New Data Highlighting The Utility Of It's Ai-based Clinical Solution In Identifying Parkinson's Disease Associated Biomarkers At Ad/pd 20241
27.02.Netramark Holdings Inc: Netramark signs fourth contract with biopharm firm1
27.02.Netramark Signs Fourth Contract With Large Biopharmaceutical Company To Enhance Clinical Trial Insights1
26.02.Netramark Holdings Inc: Netramark Holdings presents NetraAI data1
26.02.Netramark's Ai-based Technology Identifies Significant Drivers Of Efficacy And Placebo Responses And Has Potential To Improve Success Rates For Clinical Trials Of Psychiatric Medications1
15.02.Netramark To Present New Data Demonstrating The Power Of Its Ai Based Technology To De-risk Neurology Clinical Trials At Isctm Annual Meeting1
12.02.NetraMark Holdings launches NetraAI Lab1
12.02.Netramark Announces Launch Of The Netra Ai Lab1
30.01.Netramark Holdings Inc: Netramark signs 3rd contract with biopharma firm1
30.01.NetraMark signs third contract with a large biopharma company1
30.01.Netramark Signs Third Contract With Large Biopharmaceutical Company To Enhance Clinical Trial Insights1
16.01.Netramark Holdings Inc: Netramark talks publication on NetraAI research1
16.01.NetraMark's Generative AI Discovers Novel Rare Disease Drug Targets and Unique Patient Subpopulations That Could Substantially Improve Clinical Trial Success Rates1
20.12.23Netramark Holdings Inc: Netramark signs two contracts with biopharma company1
20.12.23Netramark Signs Two Contracts With Large Biopharmaceutical Company To Enhance Clinical Trial Insights1
20.11.23Netramark Holdings Inc: Netramark Holdings hires FINN Partners for PR services1
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1